Until these days, there is no certain cure to cancer. But recent experiment reveals another possible answer to the illness.

A life-changing discovery has been made, called EBC-46, the drug that could cure cancer. It made possible by researchers who managed to experiment and then conclude success to this discovery, The Guardian reported.

By extraction, compounds were found in the cherry of a blush wood tree, a plant which can only be found in specific areas of the Atherton Tablelands. This natural fruit contained the compounds that could kill cancer cells immediately.

This drug is used to treat spots of melanoma, the most deadly form of skin cancer, on animals. Amazingly, these animals on the verge of death had hope restored when Dr. Boyle and his group of scientists made this possible.

"In preclinical trials we injected it into our models and within five minutes, you see a purpling of the area that looks like a bruise," Boyle, from the QIMR Berghofer Medical Research Institute said, via Underground Reporter. "About 24 hours later, the tumor area goes black, a couple of days later you see a scab, and at around the 1.5 week mark, the scab falls off, leaving clean skin with no tumor there. The speed certainly surprised me."

They believe that the drug triggers a cellular response, which cuts off the blood supply to the tumor by opening it up. Boyle further explaining, "That's why we see a bruise-like situation forming in the tumour," Boyle said. "This seems to lead to an activation of the body's own immune system which then comes in and cleans up the mess."

But till now, there is still no proof that this fruit could kill cancer that has already spread throughout the body, a cancer known as metastatic cancer. Boyle said that while chemotherapy remains very effective for many patients, the EBC-46 could be an alternative, particularly for those who weren't successful with chemotherapy, or for elderly patients who can't sustain that treatment.

In addition, Dr. Victoria Gordon, CEO of Q-Biotics, explained how the treatment works. “We injected the drug (EBC-46) and it just seemed to liquefy (the tumour),” she said. “We’ve had no significant side effects and good results in six tumour types”. Dr. Gordon concluded there is still “a long, hard road ahead” before a pharmaceutical can be developed from the drug. Human trials had already succeeded, with 14 patients treated so far, according to 9news.